Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026)
Cartesian Therapeutics' (RNAC) quarterly EPS (Basic) came in at -$0.99 in Q1 2026, down 27.27% year-on-year from -$1.36 in Q1 2025, and up 65.76% on a QoQ basis from -$2.9 in Q4 2025.
Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of EPS (Basic) data on file, last reported at -$0.99 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 27.27% year-over-year to -$0.99 in Q1 2026; TTM through Mar 2026 was -$4.22, a 65.33% decrease from a year earlier, with the FY2025 full-year figure at -$5.02, down 11.92% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.99, up from -$2.9 in the prior quarter.
- Over the last five years, EPS (Basic) for RNAC reached as high as $2.7 in Q2 2022 and fell as low as -$38.04 in Q4 2023.
- Historically, EPS (Basic) has averaged -$3.11 across 5 years, with a median of -$1.41 in 2024.
- Across the five-year window, EPS (Basic) soared 4056.14% in 2022 and sank 3214.45% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at $1.22 in 2022, then sank by 3214.45% to -$38.04 in 2023, then soared by 96.15% to -$1.46 in 2024, then plunged by 97.92% to -$2.9 in 2025, then surged by 65.76% to -$0.99 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.99 in Q1 2026, -$2.9 in Q4 2025, and -$0.95 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Cartesian Therapeutics | 210.28 Mn | 210.28 Mn | - | -0.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.99 |
| Dec 31, 2025 | -2.90 |
| Sep 30, 2025 | -0.95 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | -0.78 |
| Dec 31, 2024 | -1.46 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | -4.59 |
| Dec 31, 2023 | -38.04 |
| Sep 30, 2023 | -1.74 |
| Jun 30, 2023 | -2.23 |
| Mar 31, 2023 | -3.75 |
| Dec 31, 2022 | 1.22 |
| Sep 30, 2022 | -1.55 |
| Jun 30, 2022 | 2.70 |
| Mar 31, 2022 | 2.43 |
| Dec 31, 2021 | 3.21 |
| Sep 30, 2021 | -4.66 |
| Jun 30, 2021 | -0.07 |